Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Recruiting Observational Study
Bone Diseases, Infectious Musculoskeletal Diseases Joint Diseases Osteoarthritis ACL Tear Cartilage Degeneration
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 50
Sex
Any
Study type
Observational
Participants needed
88 (estimated)
Sponsor
Xiaojuan Li · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Currently the diagnosis of OA is based on radiographs and clinical findings, which is limited to detecting late-stage disease. There is a pressing, unmet clinical need for robust assessment of early changes in cartilage health. Towards this goal, extensive efforts are ongoing to develop quantitative MRI for cartilage matrix analysis. MR T1ρ and T2 relaxation times have shown to be promising imagin…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Group 1 1\. Age \> 18 Group 2 1\. Age 18-50 Group 3 1. Age 18-50 2. Sustain an acute full ACL tear in one knee; the contralateral knee uninjured 3. Undergo ACL reconstructions and standard rehabilitation Group 4 1\. Age 18-50 Exclusion Criteria: Group 1 1. Contraindica…
Contacts

Xiaojuan Li, PhD

510-685-3495

lix6@ccf.org

CONTACT

Jennifer Baldwin

216 390-5833

baldwij3@ccf.org

CONTACT